1 Day
Source:
سواليف
سواليف
Ready to play
Ready to play
A phase II clinical trial involving 109 people with blood disorders that can precede leukemia found, in an exploratory analysis, that taking 1,000 mg of vitamin C daily was associated with a 65% lower risk of death over three years of follow-up. High-risk disorders developed in 5 participants in the vitamin group, compared with 9 in the placebo group, but the difference was not statistically significant. The findings therefore do not prove that the vitamin prevents cancer or prolongs life. The researchers say a larger trial is needed, and high doses should not be considered a substitute for medical follow-up or recommended treatment.
Notice: This Is an AI-Generated Summary
Comments (0)